Sustained IFN-β secretion subsequently inhibits NSCLC cell proliferation and reprograms the tumor microenvironment by increasing the infiltration levels of CD4+ T cells, M1 macrophages and NK cells. This evidence concerns the gene CD4 and neoplasm.